Cutaneous Leishmaniasis Drugs Market

What is Cutaneous Leishmaniasis Drugs?
Cutaneous leishmaniasis is a parasitic disease. It is spread by the female sandfly, which occurs in the new world and the old world. The drugs approved for cutaneous leishmaniasis treatment include fluconazole, tablet azole antifungals-systemic, Diflucan, Diflucan tablet azole antifungals-systemic, impavido, miltefosine capsule, pentam 300 solution, reconstituted, off and pentamidine 300 mg solution for injection antiprotozoal agents are.

Global Cutaneous Leishmaniasis Drugs Market Outlook
About 95% of cutaneous leishmaniasis cases occur in the Americas, the Mediterranean Basin, the Middle East, and Central Asia. In 2017 over 95% of new cutaneous leishmaniasis cases occurred in six countries: Brazil, Colombia, Afghanistan, Algeria, Iran, Iraq, and the Syrian Arab Republic. According to the World Health Organization, it is anticipated that between 600 000 to 1 million new cases arise worldwide yearly.
Cutaneous leishmaniasis cases have increased intensely in Syria and neighbouring countries due to the conflict-related displacement of Syrians. Advancement in drug therapies to provide a new treatment for cutaneous leishmaniasis. The current strategy is to control this disease mainly based on chemotherapy, presently used therapies against cutaneous leishmaniasis lead to complete cure. However, they associate with many limitations, efficacy remains hindered by the patient's age and immune system.
Lack of awareness, high cost of treatment and prolong treatment span hinders the growth of the market. World Health Organization (WHO) considers leishmaniasis to be one of the main neglected diseases in the world, affecting mostly the poor population of underdeveloped and developing countries.

Global Cutaneous Leishmaniasis Drugs Market Competitive Landscape
The "Global Cutaneous Leishmaniasis Drugs Market" study report will provide a valuable insight with an emphasis on global market including some of the major players such as GlaxoSmithKline, Novartis, Sanofi, Gilead Sciences, Bristol-Myers Squibb, Albert David, Profounda, Knight Therapeutics and Johnson & Johnson. Our market analysis also entails a section solely dedicated for such major players wherein our analysts provide an insight to the financial statements of all the major players, along with its product benchmarking and SWOT analysis.

Customization of the Report
• In case of any queries or customization requirements please connect with our sales team, who will ensure that your requirements are met.
1. INTRODUCTION OF GLOBAL CUTANEOUS LEISHMANIASIS DRUGS MARKET
1.1. Overview of the Market
1.2. Scope of Report
1.3. Assumptions

2. EXECUTIVE SUMMARY

3. RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH
3.1. Data Mining
3.2. Validation
3.3. Primary Interviews
3.4. List of Data Sources

4. GLOBAL CUTANEOUS LEISHMANIASIS DRUGS MARKET OUTLOOK
4.1. Overview
4.2. Market Dynamics
4.2.1. Drivers
4.2.2. Restraints
4.2.3. Opportunities
4.3. Porters Five Force Model
4.4. Value Chain Analysis
5. GLOBAL CUTANEOUS LEISHMANIASIS DRUGS MARKET, BY PRODUCT TYPE
5.1. Overview
5.2. Pentavalent Antimonials
5.3. Antifungal Drugs
5.4. Anti-Leishmanial/Antimicrobial Drugs

6. GLOBAL CUTANEOUS LEISHMANIASIS DRUGS MARKET, BY DISTRIBUTION CHANNEL
6.1. Overview
6.2. Hospitals Pharmacies
6.3. Retail Pharmacies
6.4. Online Pharmacies

7. GLOBAL CUTANEOUS LEISHMANIASIS DRUGS MARKET, BY GEOGRAPHY
7.1. Overview
7.2. North America
7.2.1. U.S.
7.2.2. Canada
7.2.3. Mexico
7.3. Europe
7.3.1. Germany
7.3.2. U.K.
7.3.3. France
7.3.4. Rest of Europe
7.4. Asia Pacific
7.4.1. China
7.4.2. Japan
7.4.3. India
7.4.4. Rest of Asia Pacific
7.5. Rest of the World
7.5.1. Latin America
7.5.2. Middle East & Africa

8. GLOBAL CUTANEOUS LEISHMANIASIS DRUGS MARKET COMPETITIVE LANDSCAPE
8.1. Overview
8.2. Company Market Ranking
8.3. Key Development Strategies
9. COMPANY PROFILES
9.1. GlaxoSmithKline
10.1.1 Overview
10.1.2 Financial Performance
10.1.3 Product Outlook
10.1.4 Key Developments
9.2. Novartis
9.2.1. Overview
9.2.2. Financial Performance
9.2.3. Product Outlook
9.2.4. Key Developments
9.3. Sanofi
9.3.1. Overview
9.3.2. Financial Performance
9.3.3. Product Outlook
9.3.4. Key Developments
9.4. Gilead Sciences
9.4.1. Overview
9.4.2. Financial Performance
9.4.3. Product Outlook
9.4.4. Key Developments
9.5. Bristol-Myers Squibb
9.5.1. Overview
9.5.2. Financial Performance
9.5.3. Product Outlook
9.5.4. Key Developments
9.6. Albert David
9.6.1. Overview
9.6.2. Financial Performance
9.6.3. Product Outlook
9.6.4. Key Developments
9.7. Profounda
9.7.1. Overview
9.7.2. Financial Performance
9.7.3. Product Outlook
9.7.4. Key Developments
9.8. Knight Therapeutics
9.8.1. Overview
9.8.2. Financial Performance
9.8.3. Product Outlook
9.8.4. Key Developments
9.9. Johnson & Johnson
9.9.1. Overview
9.9.2. Financial Performance
9.9.3. Product Outlook
9.9.4. Key Developments

10. Appendix
10.1. Related Reports

Global Veterinary Pain Management Drugs Market Research Report 2019-2023

Published Date : Nov 2019

In the context of China-US trade war and global economic volatility and uncertainty, it will have a big influence on this market. Veterinary Pain Management Drugs Report by Material, Application, and Geography - Global Forecast to 2023 is a professional and comprehensive research report on the world...

Global Non-steroidal Anti-inflammatory Drugs Market Research Report 2019-2023

Published Date : Nov 2019

In the context of China-US trade war and global economic volatility and uncertainty, it will have a big influence on this market. Non-steroidal Anti-inflammatory Drugs Report by Material, Application, and Geography - Global Forecast to 2023 is a professional and comprehensive research report on the ...

Global Osteoarthritis Drugs Market Research Report 2019-2023

Published Date : Nov 2019

In the context of China-US trade war and global economic volatility and uncertainty, it will have a big influence on this market. Osteoarthritis Drugs Report by Material, Application, and Geography - Global Forecast to 2023 is a professional and comprehensive research report on the world's major reg...

Global Urinary Drugs Market Research Report 2019-2023

Published Date : Nov 2019

In the context of China-US trade war and global economic volatility and uncertainty, it will have a big influence on this market. Urinary Drugs Report by Material, Application, and Geography - Global Forecast to 2023 is a professional and comprehensive research report on the world's major regional m...

Global Local Anesthesia Drugs Market Research Report 2019-2027

Published Date : Oct 2019

Local anesthetics are commonly used in the department of stomatology, ophthalmology, gynecology and some minor surgeries to temporarily relieve pain. The fundamental difference between local anaesthesia and general anaesthesia lies in that after the combination of local anaesthesia with some specifi...

Global Drugs for Lipid Metabolism Disease Market Research Report 2019-2027

Published Date : Oct 2019

Lipid Metabolism Disease Drug is usually used to help lipid metabolism. In the context of China-US trade war and global economic volatility and uncertainty, it will have a big influence on this market. Drugs for Lipid Metabolism Disease Report by Material, Application, and Geography - Global Forecas...

Global Drugs for Musculoskeletal Disorders Market Research Report 2019-2027

Published Date : Oct 2019

Musculoskeletal Disordersor MSDs are injuries anddisordersthat affect the human body's movement ormusculoskeletalsystem (i.e. muscles, tendons, ligaments, nerves, discs, blood vessels, etc.). In the context of China-US trade war and global economic volatility and uncertainty, it will have a big infl...

Global Drugs for Ophthalmology Market Research Report 2019-2027

Published Date : Oct 2019

Drugs for ophthalmology, which are used to treat eye conditions and eye diseases such as glaucoma, conjunctivitis and others. In the context of China-US trade war and global economic volatility and uncertainty, it will have a big influence on this market. Drugs for Ophthalmology Report by Material, ...

Global Dermatophytosis Drugs Market Research Report 2019-2027

Published Date : Oct 2019

Ringwormon the skin like athlete's foot (tineapedis) and jock itch (tineacruris) can usually be treated with non-prescription antifungal creams, lotions, or powders applied to the skin for 2 to 4 weeks. In the context of China-US trade war and global economic volatility and uncertainty, it will have...

Global Blood Cancer Drugs Market Research Report 2019-2027

Published Date : Sep 2019

Blood cancers, or hematologic cancers, affect the production and function of blood cells. In the context of China-US trade war and global economic volatility and uncertainty, it will have a big influence on this market. Blood Cancer Drugs Report by Material, Application, and Geography - Global Forec...

 

Select License :

  • Single User : $3950
  • Multiple User : $4750
  • Corporate User : $6750

Happy To Assist You

Assist you at Worldwide Market Reports

We will be happy to help you find what you need. Please call us or write to us:

Worldwide Market Reports Benefits

Custom Research Solution

Talk to our research consultant to design an exclusive report as per your research needs.

Customer Fulfilment

We aim to fulfil client's research demands with tailored research solutions.

Quick Turnaround Time Reports

We aim to provide research studies in quickest turnaround time and in a much cost effective manner.

360-degree Approach

We cover each industry from supply and demand side with an aim to provide a most holistic research study.